Gene Therapy for Hemophilia B

Gene therapy for Hemophilia B in China offers a breakthrough approach using AAV-F9 delivery to restore natural clotting factor production, potentially reducing or eliminating lifelong factor IX infusions.

Gene Therapy for Sickle Cell Anemia

China offers advanced gene therapy for sickle cell anemia, targeting the genetic root of the disorder. Experience potential curative outcomes, fewer transfusions, and expert treatment in world-class hospitals.

Gene Therapy for Thalassemia

China offers cutting-edge gene therapy for thalassemia, aiming to correct the genetic cause of the disorder. Experience potential curative results, reduced transfusions, and expert care in top hospitals.